Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Alogliptin/Pioglitazone on the Preservation of Long-term Beta-cell Function After Early Intensive Diabetes Treatment

NCT02823808 is registered in ClinicalTrials.gov with Kyunghee University Medical Center as lead sponsor.

NCT NCT02823808
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02823808 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Alogliptin/Pioglitazone on the Preservation of Long-term Beta-cell Function After Early Intensive Diabetes Treatment
Lead sponsor
Kyunghee University Medical Center
Phase
Phase 4
Overall status
Unknown status
Start date
July 31, 2017
Completion date
December 31, 2021
Enrollment
96 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes